logo

PRQR

ProQR Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.14 / 10
Netural

PRQR's fundamental score is 5.1/10, indicating a balanced but not outstanding position. Strengths include a high gross profit margin of 100% and positive Revenue-MV and Profit-MV factors. However, Current and Fixed assets turnover ratios are suboptimal, and the PB-ROE factor is only moderate. This mix results in a neutral fundamental rating, suggesting room for improvement in operational efficiency.

Fundamental(5.14)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-2.46
Score2/3
Weight15.77%
1M Return11.31%
Inventory turnover ratio
Value47.88
Score3/3
Weight7.12%
1M Return5.89%
Gross profit margin (%)
Value100.00
Score3/3
Weight15.75%
1M Return11.05%
Profit-MV
Value0.47
Score2/3
Weight10.87%
1M Return7.95%
Net income-Revenue
Value-0.15
Score2/3
Weight11.02%
1M Return8.04%
PB-ROE
Value0.80
Score1/3
Weight10.00%
1M Return6.78%
Current assets turnover ratio
Value0.08
Score0/3
Weight-2.52%
1M Return-2.30%
Fixed assets turnover ratio
Value0.83
Score1/3
Weight-1.44%
1M Return-1.34%
Asset-MV
Value-0.51
Score3/3
Weight22.66%
1M Return14.63%
Cash-MV
Value-0.07
Score2/3
Weight10.77%
1M Return7.78%
Is PRQR fundamentally strong?
  • PRQR scores 5.14/10 on fundamentals and holds a Fair valuation at present. Backed by its -45.68% ROE, -276.86% net margin, -3.35 P/E ratio, 2.36 P/B ratio, and -29.75% earnings growth, these metrics solidify its Netural investment rating.